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Abstract
Crescentic glomerulonephritis is an important cause of human kidney failure for which the
underlying molecular basis is largely unknown. In previous studies, we mapped several
susceptibility loci, Crgn1–Crgn7, for crescentic glomerulonephritis in the Wistar Kyoto (WKY)
rat1. Here we show by combined congenic, linkage and microarray studies that the activator
protein-1 (AP-1) transcription factor JunD is a major determinant of macrophage activity and is
associated with glomerulonephritis susceptibility. Introgression of Crgn2 from the nonsusceptible
Lewis strain onto the WKY background leads to significant reductions in crescent formation,
macrophage infiltration, Fc receptor–mediated macrophage activation and cytokine production.
Haplotype analysis restricted the Crgn2 linkage interval to a 430-kb interval containing Jund,
which is markedly overexpressed in WKY macrophages and glomeruli. Jund knockdown in rat
and human primary macrophages led to significantly reduced macrophage activity and cytokine
secretion, indicating conservation of JunD function in macrophage activation in rats and humans
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and suggesting in vivo inhibition of Jund as a possible new therapeutic strategy for diseases
characterized by inflammation and macrophage activation.
Glomerulonephritis is a major cause of human kidney failure. In its most severe form,
damage to glomerular capillaries leads to accumulation of inflammatory cells and
proliferating epithelial cells in Bowman's space, giving rise to crescentic glomerulonephritis
(CRGN), which, if untreated, usually progresses to irreversible renal scarring and end-stage
renal failure. The Wistar-Kyoto (WKY) rat shows a marked susceptibility to CRGN, as
demonstrated by susceptibility to experimentally induced nephrotoxic nephritis2 (NTN).
Recent evidence indicates that both circulating cells and intrinsic renal factors play a role in
genetic susceptibility to CRGN in the WKY rat3. Macrophages are central to the
pathophysiology of CRGN. In the inflamed glomerulus, macrophages become activated,
releasing proinflammatory cytokines, reactive oxygen species and proteases that disrupt the
integrity of the glomerular basement membrane and lead to fibrin deposition4-6. In
experimentally induced glomerulonephritis, selective depletion of macrophages ameliorates
disease7,8 and macrophage activation is central to renal injury6,9,10. Furthermore, evidence
supporting the importance of phenotypic properties of macrophages rather than their
absolute number suggests that targeting macrophage activation could have considerable
therapeutic importance in immune-mediated diseases, including glomerulonephritis6,10,11.
We recently mapped quantitative trait loci (QTLs) for CRGN susceptibility in a genome-
wide linkage analysis of F2 offspring derived from NTN-susceptible WKY and NTN-
resistant Lewis (LEW) rats1. Among seven significant QTLs, we identified two major loci
(lod score > 8), Crgn1 and Crgn2, on rat chromosomes 13 and 16, respectively, and deletion
of the rat Fcgr3-rs gene was identified as the molecular basis for Crgn1 (ref. 1). Here, we
focus on the Crgn2 locus and its effect on NTN-related phenotypes in the WKY rat.
We first evaluated the effect of Crgn2 on NTN-related phenotypes in reciprocal congenic
lines by introgression of LEW Crgn2 onto a WKY genetic background (WKY.LCrgn2) and
of WKY Crgn2 onto a LEW background (LEW.WCrgn2). WKY.LCrgn2 rats showed
significantly reduced glomerular crescent formation, fibrin deposition and macrophage
infiltration, whereas LEW.WCrgn2 rats showed significantly more proteinuria and
macrophage infiltration than the background strains, confirming that the Crgn2 linkage
region affects NTN susceptibility (Fig. 1a–d). Furthermore, Crgn2 regulates macrophage
activation and cytokine secretion, as bone marrow–derived macrophages (BMDMs) from
WKY.LCrgn2 rats showed less Fc receptor–mediated macrophage activation (Fig. 1e and
Supplementary Fig. 1a online), diminished expression of the inducible nitric oxide
synthase gene (Nos2) upon lipopolysaccharide (LPS) stimulation (Supplementary Fig. 1b),
less basal and LPS-induced monocyte chemoattractant protein-1 (MCP-1) secretion and less
LPS-induced interleukin (IL)-10 production (Fig. 1f) than WKY BMDMs.
The limits of the WKY.LCrgn2 congenic interval corresponded to a genetic interval of 22.6
cM (Supplementary Fig. 2 online), within which many candidate nucleotide variants may
be responsible for the observed phenotypic variation. We previously combined global gene
expression profiling with linkage analysis to identify positional candidate genes for insulin
resistance in the spontaneously hypertensive rat12,13. To identify positional candidates for
Crgn2, we carried out microarray analysis on normal glomeruli from WKY and LEW rats
and on glomeruli from these two strains after induction of NTN. After correction for
multiple testing, expression data of transcripts located in the Crgn2 congenic interval
showed three significantly upregulated and three significantly downregulated transcripts in
non-nephritic glomeruli of the WKY rat compared to those of the LEW (Supplementary
Table 1 online). One of these genes, the activator protein-1 (AP-1) transcription factor gene
Jund, showed a marked and highly significant increase in expression in WKY glomeruli
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compared to LEW glomeruli, both at baseline and after induction of NTN (Fig. 2a). We
confirmed Jund overexpression by quantitative RT-PCR (QRT-PCR) and also found it in
WKY BMDMs compared to LEW BMDMs (Fig. 2b and Supplementary Fig. 3a online).
Moreover, Jund expression segregated with the Crgn2 congenic interval in the Crgn2
reciprocal congenic strains. The introgressed congenic interval totally accounted for
differences in gene expression between WKY and LEW in BMDMs (Supplementary Fig.
3a). We also saw increased expression of JunD at the protein level in WKY glomeruli at day
10 after induction of NTN (Fig. 2c) Notably, Jund was not differentially expressed between
WKY and LEW basal (unstimulated) and tumor necrosis factor-α (TNF-α)-stimulated
mesangial cells (Supplementary Fig. 3b), suggesting that the development of NTN is not
secondary to changes in mesangial cell Jund expression. Sequence analysis of the WKY and
LEW Jund promoters revealed a C/T polymorphism in the vicinity (+2 bp) of an octamer
motif in the Jund promoter, 210 bp upstream of the transcription initiation site (Fig. 2d). To
test whether the C/T polymorphism in the Jund promoter accounts for the interstrain
differences in gene expression, we cloned Jund promoter sequences from LEW and WKY
into a pGL3-Basic luciferase expression vector and assessed promoter activity in COS7
cells. The WKY promoter sequence containing the T allele showed greater relative
luciferase activity than the LEW sequence containing the C allele (Fig. 2e). JunD binding to
the AP-1 consensus sequence (5′-TGAGTCA-3′) was also significantly higher in WKY
BMDMs than in WKY.LCrgn2 (Fig. 2f). Because the C/T promoter polymorphism might
have been be responsible, at least in part, for the increased Jund expression observed in
WKY rats, we used this polymorphism to genotype 177 F2 rats derived from WKY and
LEW in a PCR-based amplification-refractory mutation system (ARMS) assay in order to
define the location of Jund within the Crgn2 interval. The Jund C/T promoter polymorphism
showed complete linkage disequilibrium with the microsatellite marker D16Rat78, which
previously mapped to the Crgn2 peak of linkage1 and was significantly linked to glomerular
crescents, proteinuria and macrophage infiltration (Fig. 3a and Supplementary Fig. 4
online).
To refine the linkage to glomerular macrophage infiltration within Crgn2, we assessed
macrophage infiltration after injection of nephrotoxic serum in four closely related Kyoto-
derived strains of rat and found that IS/KYO had macrophage infiltration comparable to
Lewis, whereas WKY, WTC, WKYO and DON had increased infiltration of macrophages
(Fig. 3b). Haplotype analysis on chromosome 16 defined a maximal region of 430 kb that
segregated with increased macrophage infiltration across the strains (Fig. 4a,b). Within this
430-kb region, Jund was the only transcript from the microarray analysis that showed
overexpression in WKY compared to LEW glomeruli in either the basal state (Fig. 4a,b and
Supplementary Table 1) or the NTN-induced state (data not shown). This excluded the
other five transcripts that were observed to be differentially expressed, as they mapped
outside the 430 kb interval (Fig. 4a). These results strongly implicate Jund as a positional
candidate for increased macrophage activation and cytokine production and for glomerular
macrophage infiltration encoded at the Crgn2 locus.
JunD is an AP-1 transcription factor. It is ubiquitously expressed and reported to function as
a negative regulator of cell proliferation and to protect against apoptosis and oxidative
stress14-16. AP-1 is known to be activated in glomeruli in experimental glomerulonephritis
in rats17-20. Although JunD regulates the transcriptional activity of TH2 cytokines21, its
role in macrophage activation and inflammatory disorders has not been investigated. To test
whether JunD regulates rat macrophage activation, we reduced Jund expression by small
interfering RNA (siRNA) in WKY BMDMs and measured subsequent macrophage
activation. Knockdown of Jund in WKY BMDMs (Fig. 5a) resulted in significantly reduced
Fc receptor–mediated macrophage activation (Fig. 5b) and LPS-induced Nos2 expression
(Fig. 5c), showing that Jund regulates macrophage activation and that its expression levels
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play a key role in the pathophysiology of CRGN in the WKY rat by determining a specific
macrophage phenotype.
The heterogeneity of activated macrophages is characterized by different functional
activation states. These macrophage phenotypes reflect different genetic susceptibilities to
experimentally induced autoimmunity in the rat22. To test whether Jund expression levels
affect macrophage activation in humans, we measured cytokine secretion in basal and LPS-
treated human primary macrophages after reduction of Jund expression by treatment with
siRNA. We found that siRNA knockdown of Jund (Fig. 6a,b) in human primary
macrophages significantly reduced LPS-induced secretion of IL-10, TNF-α and IL-6 (Fig.
6c), showing that Jund mRNA levels directly regulate the secretion of these cytokines in
human primary macrophages.
Genome-wide linkage analysis from NTN-susceptible WKY and NTN-resistant LEW rats
showed linkage to seven loci, including Crgn2, that influence glomerular crescents,
proteinuria and macrophage infiltration (Fig. 3 and ref. 1). The present studies have
confirmed, by introgression of the Crgn2 locus onto the LEW or WKY genetic backgrounds
in reciprocal congenic strains, that Crgn2 influences development of glomerular crescents
and proteinuria, fibrin deposition and macrophage infiltration and have also shown that
Crgn2 regulates activation and cytokine secretion of BMDMs. Gene expression studies in
WKY and LEW rats and in the congenic LEW.WCrgn2 strain showed marked differential
expression of Jund, which was located at the Crgn2 peak of linkage. Overexpression of Jund
segregated with the WKY allele of Jund, indicating that Jund over-expression in the WKY
strain is regulated in cis by polymorphism(s) within the Crgn2 congenic segment. Haplotype
mapping restricted the region of linkage to macrophage infiltration to a maximal interval of
430 kb, within which Jund was the only transcript from our microarray analysis showing
different expression in WKY than in LEW glomeruli. Luciferase assay showed that Jund
overexpression in WKY rats was mediated, at least in part, by a C/T polymorphism in the
Jund promoter. In addition, increased Jund expression in WKY BMDMs was characterized
by increased binding of JunD protein to the AP-1 consensus sequence. Taken together with
our observations that Jund knockdown reduced macrophage activation in rats and cytokine
production in humans, these data strongly implicate Jund as a primary determinant of
macrophage activation and of CRGN in the WKY rat.
The reciprocal congenic lines showed significant, though small, alterations in NTN
phenotypes (Fig. 1a–d), although not all these phenotypes were altered in both of the
reciprocal congenic strains. This suggests that Crgn2 is necessary but not sufficient to
capture all the NTN-related phenotypic effects and that interaction between Crgn2 and the
other NTN-susceptibility loci may be required for full expression of or protection from the
NTN phenotypes.
Although we have shown that intrinsic renal cells play a role in development of NTN in
WKY rats3, we found no evidence for dysregulated Jund expression in renal mesangial
cells. JunD is known to regulate T cell activity21, and the nephritic WKY kidney contains
abundant CD8+ cells, but our previous studies indicated that these CD8+ cells are of the
monocyte/macrophage lineage, with very few cells expressing other T-cell surface
markers2. It is therefore most likely that Jund mediates NTN susceptibility through the
effects that we have shown on macrophage activity and cytokine production.
In conclusion, our study suggests that overactivation of macrophages owing to genetically
mediated overexpression of Jund is functionally linked to inflammation-mediated
autoimmune disease susceptibility. Local or systemic knockdown of JunD should be
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considered as a potential therapeutic approach to the treatment of inflammatory diseases
characterized by macrophage infiltration and activation.
METHODS
Rats
Wistar-Kyoto (WKY/NCrl, designated here as WKY) and Lewis (LEW/Crl, designated
LEW) rats were purchased from Charles River. WTC, WKYO, DON and IS/KYO rats were
obtained from T. Serikawa (Institute of Laboratory Animals, Japan). Lewis/HanHsd rats for
microarray experiments were purchased from Harlan. F1 rats were generated by
intercrossing the two strains. All procedures were performed in accordance with the United
Kingdom Animals (Scientific Procedures) Act.
Generation of congenic rat lines
To investigate the involvement of the chromosome 16 QTL in the NTN phenotype, we
produced congenic rat lines by introgression of segments of interest on chromosome 16,
Crgn2 (D16Rat88–D16Rat40) from the WKY donor onto the Lewis recipient genome and
vice versa. Crgn2 congenics on both WKY (WKY.LEW-D16Rat88/D16Rat40, designated
as WKY.LCrgn2) and Lewis (LEW.WKY-D16Rat88/D16Rat40, designated as
LEW.WCrgn2) genetic backgrounds were generated by backcrossing the (WKY × LEW) F1
rats to WKY and Lewis parental strains for nine generations. Rats heterozygous for the
chromosome-16 linkage region were brother-sister mated to fix the congenic interval and
obtain the congenic lines.
NTN induction
Nephrotoxic serum was prepared in rabbits as previously described23. We induced
nephrotoxic nephritis in male rats by intravenous injection of 0.1 ml of nephrotoxic serum.
Nine days later urine was collected by placing rats into metabolic cages for 24 h with free
access to food and water. Proteinuria was determined by the sulfosalicylic acid method3. On
day 10 after induction of NTN, we killed rats under isoflurane anesthesia and collected
blood from the abdominal aortas. Samples of kidney, skin, liver, colon and lung were fixed
in formalin, buffered 10% (wt/vol in phosphate buffer), processed and embedded in paraffin
wax.
Bone marrow–derived macrophage culture, Fc oxyBURST and bead phagocytosis assays
We isolated femurs from adult rats and flushed them with Hank's buffer (Gibco). Total bone
marrow–derived cells were plated and cultured for 5 d in DMEM (Gibco) containing 25 mM
HEPES buffer (Sigma), 25% L929 conditioned media, 25% decomplemented fetal bovine
serum (F-539, M.B. Meldrum), penicillin (100 U/ml, Invitrogen), streptomycin (100 μg/ml,
Invitrogen) and L-glutamine (2 mM, Invitrogen). Nonadherent cells were removed by
changing the media and culturing the cells for another 2 d. Rat cells were characterized as
macrophages by ED-1 staining. For Fc oxyBURST assay, 106 cells (in triplicate) were
suspended in Krebs' Ringer's PBS (KRP buffer) with 1.0 mM Ca2+, 1.5 mM Mg2+ and 5.5
mM glucose, warmed to 37 °C and stimulated with Fc oxyBURST reagent (240 μg/ml,
Invitrogen). Individual data points consisting of 10,000 fluorescence events were collected
at 0, 15, 30, 45, 60, 90 and 120 s in a FACSCalibur after a baseline fluorescence reading was
taken to determine the intrinsic fluorescence of the unstimulated cells. Percentage of
fluorescent BMDMs corresponds to percentage of activated gated cells after Fc receptor–
mediated phagocytosis.
We assessed macrophage bead phagocytosis as described24. Briefly, after differentiation,
BMDMs were collected and cultured for 2 d in eight-well glass chamber slides (Nunc) at
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105 macrophages per well. Two hours before adding the beads, we washed macrophages in
warm Hank's (Gibco) and added serum-free DMEM. We then added 6-μm polystyrene
beads opsonized and unopsonized with rabbit anti-BSA IgG (Sigma) (Polysciences) to wells
at 20 beads per target cell. The chamber slides were then incubated at 37 °C, 5% CO2 for ten
minutes washed in PBS and fixed in cold methanol before a Diffquik stain (Medion
Diagnostics) was performed. We counted 100 BMDMs in a blinded manner, noting the
number of beads ingested. Each condition was carried out in duplicate, and the experiment
was repeated with three separate rats.
Rat mesangial cell culture
Glomeruli from Lewis and WKY rats were isolated by sieving. Purified glomeruli were
digested with collagenase type 1 (Sigma; 750 U/ml) for 20 min. Partially digested glomeruli
were cultured in 25-cm2 tissue culture flasks at 600 glomeruli per milliliter in RPMI 1640
medium (Invitrogen) that contained 20% decomplemented FBS (F-539), penicillin (100 U/
ml; Invitrogen), streptomycin (100 μg/ml; Invitrogen), L-glutamine (2 mM, Invitrogen) and
insulin-transferrin-selenite mixture (Sigma). The cultures were maintained at 37 ° with 5%
CO2 for 6 d, allowing glomerular mesangial cells to grow out. We characterized cells as
mesangial cells as previously described3.
Primers
See Supplementary Table 2 online.
Gene expression profiling and quantitative RT-PCR
Total RNA was extracted from WKY and LEW glomeruli and cRNA synthesized from 10
μg total RNA and purified according to Affymetrix's recommendations. We used the
Affymetrix Rat Genome U34 Set on RNA extracted from WKY and LEW glomeruli (n = 3
rats per condition) with or without NTN induction. We extracted rat BMDM and glomerular
RNA using Trizol (Invitrogen) and performed Jund QRT-PCR using gene-specific primers
as previously described3.
ARMS analysis
To determine genotype at the C/T polymorphism in the Jund promoter, we performed PCR
using a WKY T allele–specific reverse primer or a LEW C allele–specific primer with a
common forward primer, together with β-actin primers as a control of the PCR. Two PCR
reactions were performed for a single DNA product (125 ng). After amplification, PCR
products were analyzed on a 2.5% agarose gel and genotypes were determined according to
the presence or absence of allele-specific bands.
Haplotype map
Genotypes and a subsequent haplotype map of the Crgn2 QTL were generated from
genomic DNA of WKY, LEW and Kyoto-derived strains for 12 markers (D16Mit3,
D16Rat43, D16Rat73, D16Rat76, D16Rat78, D16Rat82, D16Arb5, D16Rat32, D16Rat88,
D16Got22, Jund1 and oxsts5626) spread across the 14-cM region of linkage. Genetic
location of the markers was obtained from BN × SHRSP cross from Rat Genome Database
(see URLs below). Physical marker locations on Crgn2 were obtained from Ensembl (see
URLs). The Jund promoter polymorphism was genotyped by direct sequence analysis of
PCR products amplified from genomic DNA of WKY, LEW and Kyoto-derived strains.
Fluorescently labeled microsatellite PCR products were separated on an ABI 3730xl
(Applied Biosystems) and scored using GeneMapper Software v3.7.
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Jund promoter polymorphism and luciferase assay
The Jund promoter sequence was determined by direct sequencing using 100 ng of WKY
and LEW genomic DNA in an ABI 3730xl (Applied Biosystems).
At 48 h before transfection, we seeded COS7 cells onto 96-well plates at a density of 2.5 ×
104 cells per well. In order to detect maximum and minimum promoter activities, we
transfected the cells with either pGL3-Control (200 ng, Promega) or pGL3-Basic (200 ng,
Promega), together with 200 ng of the internal control reporter Renilla reniformis luciferase
driven under the SV40 promoter (pRL-SV40; Promega) for normalizing for the transfection
efficiency. Transfections were performed using Lipofectamine 2000 reagent (Invitrogen). In
order to compare WKY and Lewis Jund promoter activities, we amplified 300 bp of the
Jund promoter containing the C/T polymorphism by PCR using KOD Hot Start DNA
Polymerase (1 U/μl, Novagen) from WKY and LEW genomic DNA, introducing NheI and
HindIII restriction sites in the 5′ end of forward and reverse primers. The PCR products
obtained from WKYand Lewis genomic DNA were subsequently cloned into pGL3-Basic
vectors and were transfected into COS7 cells, together with 200 ng of pRL-SV40. After
washing them in PBS, we resuspended cells in 250 μl of lysis buffer. Luciferase assay was
performed using the dual luciferase assay system kit according to the manufacturer's
protocols (Promega). Values for the relative promoter activity were calculated from the ratio
of firefly:Renilla luciferase activities using a luminometer (FluoStar).
siRNA inhibition of Jund expression
Human primary macrophages were derived from elutriated monocytes by culturing the cells
with macrophage colony-stimulating factor at 100 ng/ml (Peprotech) in RPMI 1640
containing 10% heat-inactivated FCS for 3 d as previously described25. WKY BMDMs and
human primary macrophages were plated in six-well plates (106 cells per well) in DMEM
(Gibco) for 24 h and transfected for 48 h with the siGENOME SMARTpool (100 nM,
Dharmacon), which consists of four unique siRNAs against rat Jund and double-stranded
nontargeting siRNA, using Dharmafect 1 (1:50, Dharmacon) as a transfection reagent in
OPTIMEM medium (Gibco).
Nuclear extraction
Nuclear extracts were prepared from control (unstimulated) or LPS-stimulated (100 ng/ml,
Sigma) BMDMs. We washed cells once with PBS and lysed them in the presence of
protease/phosphatase inhibitor cocktail using the Active Motif nuclear extract preparation
kit. Extracts were stored at −80 °C until use.
JunD TransAM assay
Nuclear extracts, equivalent to 10 μg protein, obtained from control and LPS (100 ng/ml)-
stimulated WKY, LEW and WKY.LCrgn2 BMDMs were analyzed by TransAM assay
(Active Motif). Nuclear proteins were incubated with consensus TPA-response element
(TRE) oligonucleotides (5′-TGAGTCA-3′) of the AP-1 binding motif immobilized on 96-
well assay plates and probed with antibodies specific to JunD. Plates were developed after
addition of secondary antibody and colorimetric developing solution in accordance with
manufacturer's instructions, and read on an Anthos ht III (Anthos Labtec) spectrophotometer
at 450 nm.
Protein blot analysis of JunD
Human macrophage cell extracts were resolved by SDS-PAGE and transferred to
polyvinylidene difluoride membranes (Millipore), which were blocked for 1 h with blocking
buffer (5% (wt/vol) fat-free milk and 0.1% (vol/vol) Tween-20 in PBS) and then incubated
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for 1 h with rabbit polyclonal JunD antibody (Santa Cruz) diluted 1:500 in blocking buffer.
HRP-conjugated anti-rabbit IgG (Amersham Pharmacia Biotech) was used as a secondary
antibody at a dilution of 1:2,000. Bound antibody was detected using the ECL kit
(Amersham Pharmacia Biotech) and visualized using RX Medical X Ray film (Fujifilm).
Cytokine determination by ELISA
We carried out sandwich ELISAs for human IL-10, TNF-α, IL-6 (PharMingen
International) and rat MCP-1, IL-10 (BD Biosciences), in accordance with the
manufacturers' specifications, with supernatants from BMDMs plated in six-well plates at a
density of 106 cells per well and incubated in 2 ml of culture medium for 24 h. For rat
BMDMs, ELISA was performed with control (unstimulated) and LPS-stimulated (100 ng/
ml) cells. For human primary macrophages, ELISA was performed with (10 ng/ml) or
without LPS stimulation after siRNA transfection.
Statistical analysis
All data were analyzed by Student's t-test or analyses of variance followed by post hoc
comparisons. Differences in relative mRNA levels and human cytokine quantities were
tested for significance with the nonpara-metric Wilcoxon signed-rank test. Affymetrix U34
chip data was loaded into Rosetta Resolver and intensity profiles were normalized by the
Affymetrix-Rosetta's Experiment Builder. Gene expression measurements at the probe level
were analyzed using error weighted, one-way analysis of variance between WKY and LEW
control glomeruli (WKYc,LEWc) and glomeruli after NTN induction (WKYNTN and
LEWNTN) followed by a Scheffé post hoc test. P values of the expression data reported in
the text were adjusted for multiple testing using the Benjamini and Hochberg false discovery
rate method.
URLs
Rat Genome Database, http://rgd.mcw.edu/. Ensembl, http://www.ensembl.org.
Accession codes
ArrayExpress: The microarray experiment on WKY, LEW control and NTN glomeruli has
been submitted to ArrayExpress with accession code E-MEXP-1294.
Acknowledgments
We thank P. Froguel, E. Petretto and S. Cook for criticism of the manuscript. We thank T. Serikawa and the
National Bio Resource Project in Japan for providing the Japanese rat strains. We acknowledge intramural funding
from the Clinical Sciences Centre and support from the FP6 EURATools (European Union contract number LSHG-
CT-2005-019015), the UK Medical Research Council and the Wellcome Trust. H.T.C, C.D.P., A.S. and T.J.A.
acknowledge support from the UK National Institute for Health Research's Biomedical Research Centre funding
scheme.
References
1. Aitman TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and
humans. Nature. 2006; 439:851–855. [PubMed: 16482158]
2. Tam FW, et al. Development of scarring and renal failure in a rat model of crescentic
glomerulonephritis. Nephrol. Dial. Transplant. 1999; 14:1658–1666. [PubMed: 10435873]
3. Smith J, et al. Genes expressed by both mesangial cells and bone marrow-derived cells underlie
genetic susceptibility to crescentic glomerulonephritis in the rat. J. Am. Soc. Nephrol. 2007;
18:1816–1823. [PubMed: 17475818]
4. Lai PC, et al. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats. J. Am. Soc.
Nephrol. 2001; 12:2310–2320. [PubMed: 11675407]
Behmoaras et al. Page 8
Nat Genet. Author manuscript; available in PMC 2009 September 11.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
5. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int. 1994; 45:945–952. [PubMed:
8007597]
6. Cook HT, et al. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Kidney Int. 1999; 55:1319–1326. [PubMed: 10200996]
7. Isome M, et al. Important role for macrophages in induction of crescentic anti-GBM
glomerulonephritis in WKY rats. Nephrol. Dial. Transplant. 2004; 19:2997–3004. [PubMed:
15574997]
8. Duffield JS, et al. Conditional ablation of macrophages halts progression of crescentic
glomerulonephritis. Am. J. Pathol. 2005; 167:1207–1219. [PubMed: 16251406]
9. Cook HT, Smith J, Salmon JA, Cattell V. Functional characteristics of macrophages in
glomerulonephritis in the rat. O2– generation, MHC class II expression, and eicosanoid synthesis.
Am. J. Pathol. 1989; 134:431–437. [PubMed: 2537019]
10. Kluth DC. Pro-resolution properties of macrophages in renal injury. Kidney Int. 2007; 72:234–236.
[PubMed: 17653230]
11. Wang Y, et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory
renal disease. Kidney Int. 2007; 72:290–299. [PubMed: 17440493]
12. Aitman TJ, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty
acid and glucose metabolism in hypertensive rats. Nat. Genet. 1999; 21:76–83. [PubMed:
9916795]
13. Pravenec M, et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in
spontaneously hypertensive rats. Nat. Genet. 2001; 27:156–158. [PubMed: 11175782]
14. Pfarr CM, et al. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation
by ras. Cell. 1994; 76:747–760. [PubMed: 8124713]
15. Weitzman JB, Fiette L, Matsuo K, Yaniv M. JunD protects cells from p53-dependent senescence
and apoptosis. Mol. Cell. 2000; 6:1109–1119. [PubMed: 11106750]
16. Gerald D, et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell.
2004; 118:781–794. [PubMed: 15369676]
17. Sakurai H, et al. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in
experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim.
Biophys. Acta. 1997; 1362:252–262. [PubMed: 9540856]
18. Sakurai H, Sugita T. c-Jun N-terminal kinase-mediated AP-1 activation in experimental
glomerulonephritis in rats. Biochem. Mol. Biol. Int. 1998; 45:831–839. [PubMed: 9713708]
19. Flanc RS, et al. A pathogenic role for JNK signaling in experimental anti-GBM
glomerulonephritis. Kidney Int. 2007; 72:698–708. [PubMed: 17597698]
20. Ikezumi Y, Hurst L, Atkins RC, Nikolic-Paterson DJ. Macrophage-mediated renal injury is
dependent on signaling via the JNK pathway. J. Am. Soc. Nephrol. 2004; 15:1775–1784.
[PubMed: 15213265]
21. Meixner A, Karreth F, Kenner L, Wagner EF. JunD regulates lymphocyte proliferation and T
helper cell cytokine expression. EMBO J. 2004; 23:1325–1335. [PubMed: 15029240]
22. Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA. Differential macrophage
expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune
susceptibility. J. Leukoc. Biol. 2004; 76:1118–1124. [PubMed: 15371491]
23. Bhan AK, Schneeberger EE, Collins AB, McCluskey RT. Evidence for a pathogenic role of a cell-
mediated immune mechanism in experimental glomerulonephritis. J. Exp. Med. 1978; 148:246–
260. [PubMed: 78959]
24. May RC, Caron E, Hall A, Machesky LM. Involvement of the Arp2/3 complex in phagocytosis
mediated by FcγR or CR3. Nat. Cell Biol. 2000; 2:246–248. [PubMed: 10783245]
25. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is
the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J.
Immunol. 2004; 172:567–576. [PubMed: 14688368]
Behmoaras et al. Page 9
Nat Genet. Author manuscript; available in PMC 2009 September 11.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 1.
Nephrotoxic nephritis (NTN) and macrophage phenotypes in parental (WKY, Lewis) and
chromosome 16 congenic strains (WKY.LCrgn2, LEW.WCrgn2). For NTN phenotypes, rats
were killed 10 d after injection of nephrotoxic serum. (a–d) Glomerular crescents (a), fibrin
deposition (b), macrophage infiltration defined by ED-1–positive cells per glomerular cross-
section (c) and proteinuria (d), measured using at least four rats per strain. (e) Macrophage
activation, assessed by Fc receptor mediated phagocytosis and oxidization. WKY, LEW and
WKY.LCrgn2 BMDMs (three rats per strain) were stimulated with Fc oxyBURST. LEW
and WKY.LCrgn2 BMDMs showed significantly less activation than WKY at all time
points (P < 0.001; error bars, s.e.m.). (f) Sandwich ELISA for secretion of MCP-1 in basal
(unstimulated) and LPS (100 ng/ml)-stimulated BMDMs; secretion of IL-10 in LPS-
stimulated (100 ng/ml) WKY, LEW and WKY.LCrgn2 BMDMs. *P < 0.05 and **P < 0.001
compared to WKY; error bars, s.e.m.
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Figure 2.
Jund expression and protein levels in the NTN-susceptible WKY rat. (a,b) Microarray (a)
and QRT-PCR (b) analyses showed that Jund expression is higher in WKY than in LEW
glomeruli at baseline (WKYc, LEWc) and in NTN-induced glomeruli (WKYNTN, and
LEWNTN). At least three rats per strain and per condition (control or NTN) were used. Error
bars, s.e.m. (c) Immunostaining for JunD protein in WKY and Lewis glomeruli after NTN
induction (day 10), showing increased JunD in the WKY glomeruli. (d) Sequence analysis
of the rat Jund promoter, showing a C/T polymorphism at −210 bp (asterisk) in the vicinity
of an octamer binding motif (−219 to −212 bp). (e) Luciferase assay performed after
transfecting COS7 cells with pGL3-Basic vector containing, 300 bp upstream of the
transcription initiation site, either the WKY or LEW Jund promoters (pGL3-WKY and
pGL3-LEW, respectively). Firefly luciferase activity, normalized to Renilla luciferase
activity, is expressed relative to the activity of the empty pGL3-Basic vector. Error bars,
s.e.m. for five different transfection experiments performed in replicates of six. (f) JunD
binding to AP-1 site in BMDMs. Specific JunD binding to AP-1 consensus sequence
nucleotides (5′-TGAGTCA-3′) was greater in WKY BMDM nuclear extracts than in LEW
and WKY.LCrgn2 by TransAM assay. A450, absorbance at 450 nm. *P < 0.05; error bars,
s.e.m.
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Figure 3.
Combined gene expression and genetic mapping for NTN susceptibility in rat. Rat Jund
promoter polymorphism between WKY and LEW was used to genotype 177 F2 rats derived
from WKY and LEW by PCR-based ARMS assay (see also Supplementary Fig. 4). (a)
NTN phenotypes versus Jund genotype. *P < 0.05; **P < 0.01; *** P < 0.001, compared to
C/C genotype. Error bars, s.e.m. (b) Macrophage infiltration determined by quantitative
analysis of ED-1–positive cells in the glomeruli (including the Bowman's space) in WKY,
LEW and four Kyoto-derived rat strains, 10 d after NTN induction. *P < 0.001 compared to
LEW; NS, nonsignificant.
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Figure 4.
Chromosome 16 haplotype analysis. (a) Crgn2 genetic map. High and low macrophage
infiltration denote, respectively, strains with macrophage infiltration that is or is not
significantly greater than that in the LEW strain. Numbers denote classification of alleles: 1,
LEW; 2, WKY; 3 and 4, other alleles. Genetic locations of other significantly differentially
expressed genes in the overall Crgn2 congenic interval are also indicated. The boxed area
corresponds to microsatellite markers (D16Rat78 and D16Rat82) mapping to the peak of
linkage in Crgn2. Genetic distances are indicated in cM. (b) Fine haplotype mapping
delineates a maximal 430-kb region of haplotypic identity segregating with macrophage
infiltration. Physical location of the markers is indicated in Mbp. The Jund C/T promoter
polymorphism showed the same haplotype as D16Got22 and Jund1.
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Figure 5.
Effect of modulating Jund expression on macrophage activity. (a–c) WKY BMDMs were
cultured (n = 3 rats) and transfected either with Jund siRNA or control (nontargeting)
siRNA. Jund mRNAs were measured 48 h after transfection by QRT-PCR (a) and
macrophage activation was assessed by Fc oxyBURST assay (b) and by measuring Nos2
expression in basal (unstimulated) and LPS-stimulated (100 ng/ml) cells (c). WKY BMDMs
with Jund knockdown showed significantly less Fc receptor–mediated activation at all time
points than BMDMs transfected with control siRNA (P < 0.001); NS, nonsignificant. Error
bars, s.e.m.
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Figure 6.
JunD expression and cellular activation in human primary macrophages. Human
macrophages from five healthy donors were derived from elutriated monocytes. Five
independent experiments were performed in which cells were incubated either with Jund
siRNA (100 nM) or control (nontargeting) siRNA (100 nM) for 48 h and stimulated with
LPS (10 ng/ml) for 24 h. (a) QRT-PCR for human Jund. (b) JunD and p38 protein blotting.
(c) IL-10, TNF-α and IL-6 relative secretion were assessed by sandwich ELISA in basal
(unstimulated) and 24 h LPS-stimulated (10 ng/ml) cell supernatants. Error bars, s.e.m.
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